Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.

Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.

Item
http://www.wikidata.org/entity/Q43033068
Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewInflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort studyIP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection.Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver diseaseImmune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infectionSerum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis.Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-α in Chronic Hepatitis C Virus Patients.Influence of cytokine and cytokine receptor gene polymorphisms on the degree of liver damage in patients with chronic hepatitis C.IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B.Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.Transforming growth factor-β genetic polymorphisms on development of liver cirrhosis in a meta-analysis.Cytokine expression in spleen affects progression of liver cirrhosis through liver-spleen cross-talk.Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented ReviewDetermination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail
P2860

Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.

Item
http://www.wikidata.org/entity/Q43033068
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Twelve potential fibrosis mark ...... hronic hepatitis C genotype 1.
@en
Twelve potential fibrosis mark ...... hronic hepatitis C genotype 1.
@nl
type
label
Twelve potential fibrosis mark ...... hronic hepatitis C genotype 1.
@en
Twelve potential fibrosis mark ...... hronic hepatitis C genotype 1.
@nl
prefLabel
Twelve potential fibrosis mark ...... hronic hepatitis C genotype 1.
@en
Twelve potential fibrosis mark ...... hronic hepatitis C genotype 1.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Twelve potential fibrosis mark ...... hronic hepatitis C genotype 1.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921